Literature DB >> 7263069

Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil.

C Carelli, F Audibert, L Chedid.   

Abstract

Circulating antibody titers can be increased when the antigen is administered in an aqueous medium with N-acetylmuramyl-L-alanyl-D-isoglutamine (muramyl dipeptide). Results reported here show that cell-mediated immunity can be demonstrated when this synthetic adjuvant or an active analog is injected with an antigen (ovalbumin) in metabolizable squalane emulsion. Under these conditions a lipophilic derivative of muramyl dipeptide was shown to be even more active and to enhance long-lasting immune responses.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7263069      PMCID: PMC350692          DOI: 10.1128/iai.33.1.312-314.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble components.

Authors:  F Audibert; L Chédid; P Lefrancier; J Choay
Journal:  Cell Immunol       Date:  1976-02       Impact factor: 4.868

2.  Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.

Authors:  F Ellouz; A Adam; R Ciorbaru; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1974-08-19       Impact factor: 3.575

3.  Freund's adjuvants: relationship of arthritogenicity and adjuvanticity in rats to vehicle composition.

Authors:  M W Whitehouse; K J Orr; F W Beck; C M Pearson
Journal:  Immunology       Date:  1974-08       Impact factor: 7.397

4.  Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds.

Authors:  I Azuma; K Sugimura; T Taniyama; M Yamawaki; Y Yamamura
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

5.  The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on the antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin.

Authors:  R Bomford
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

6.  Tumor regression after intralesional injection of mycobacterial components emulsified in 2,6,10,15,19,23-hexamethyl-2,6,10,14,18,22-tetracosahexaene (squalene), 2,6,10,15,19,23-hexamethyltetracosane (squalane), peanut oil, or mineral oil.

Authors:  E Yarkoni; H J Rapp
Journal:  Cancer Res       Date:  1979-05       Impact factor: 12.701

7.  Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids.

Authors:  S Kotani; Y Watanabe; F Kinoshita; T Shimono; I Morisaki
Journal:  Biken J       Date:  1975-06

8.  Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.

Authors:  M A Parant; F M Audibert; L A Chedid; M R Level; P L Lefrancier; J P Choay; E Lederer
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

9.  Immunotherapy of experimental cancer with a mixture of synthetic muramyl dipeptide and trehalose dimycolate.

Authors:  E Yarkoni; E Lederer; H J Rapp
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

10.  Stimulation of thymocyte mitogenic protein secretion and of cytostatic activity of mouse peritoneal macrophages by trehalose dimycolate and muramyldipeptide.

Authors:  J P Tenu; E Lederer; J F Petit
Journal:  Eur J Immunol       Date:  1980-08       Impact factor: 5.532

View more
  7 in total

1.  Enhancement of resistance to Escherichia coli infection in mice by dihydroheptaprenol, a synthetic polyprenol derivative.

Authors:  S Araki; K Kagaya; K Kitoh; M Kimura; Y Fukazawa
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

2.  New approaches for control of infections using synthetic or semi-synthetic constructs containing MDP.

Authors:  L Chedid; F Audibert
Journal:  Springer Semin Immunopathol       Date:  1985

3.  Modulation of natural killer cytotoxicity by muramyl dipeptide and trehalose dimycolate incorporated in squalane droplets.

Authors:  K N Masihi; W Lange; B Rohde-Schulz
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

4.  Stimulation of chemiluminescence by synthetic muramyl dipeptide and analogs.

Authors:  K N Masihi; I Azuma; W Brehmer; W Lange
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

5.  Stimulation of chemiluminescence and resistance against aerogenic influenza virus infection by synthetic muramyl dipeptide combined with trehalose dimycolate.

Authors:  K N Masihi; W Brehmer; I Azuma; W Lange; S Müller
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

6.  New muramyl dipeptide (MDP) mimics without the carbohydrate moiety as potential adjuvant candidates for a therapeutic hepatitis B vaccine (HBV).

Authors:  Nan Zhao; Yao Ma; Shengmei Zhang; Xin Fang; Zhenglun Liang; Gang Liu
Journal:  Bioorg Med Chem Lett       Date:  2011-05-25       Impact factor: 2.823

Review 7.  Squalene emulsions for parenteral vaccine and drug delivery.

Authors:  Christopher B Fox
Journal:  Molecules       Date:  2009-09-01       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.